🔎 Trials Near Me

Hjem › Hjerteanfald › Kansas

Hjerteanfald kliniske forsøg i Kansas

3 studier for Hjerteanfald søger deltagere på steder i Kansas.

Officiel studietekst (engelsk)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Kansas Nephrology Physicians, PA, Wichita
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • University of Kansas Hospital, Kansas City
  • Cotton O Neil Clinical Res Center, Topeka
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 4. sep. 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Hutchinson Clinic PA, Hutchinson
  • University of Kansas Medical Center, Kansas City
  • Midwest Heart and Vascular Specialists, Overland Park
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.